The Office of the Director (OD) at the National Cancer Institute (NCI) announces this notice of special interest (NOSI) to encourage current grant or cooperative agreement awardees to extend their funded studies to investigate uterine serous carcinoma (USC). To be eligible for these supplemental funds, parent grants must currently focus on (1) endometrial cancer; (2) TP53 aberrant tumors; (3) serous ovarian cancer; (4) development of in vitro and in vivo model systems; or (5) cancer health disparities. The overall goal of these administrative supplements is to advance knowledge in the tumor biology (including the tumor microenvironment), prevention, diagnosis, early detection, treatment, risk assessment, or the health disparity issues of USC that would lead to future benefits for patients with this disease.
Brief Description